Evidence map›Paper›PMID 35056082›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

Differential Influence of

Michał Szulc, Radosław Kujawski, Justyna Baraniak, Małgorzata Kania-Dobrowolska, Ewa Kamińska, Agnieszka Gryszczyńska, Kamila Czora-Poczwardowska, Hanna Winiarska, Przemysław Ł Mikołajczak

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Michał SzulcDepartment of Pharmacology, Poznań University of Medical Sciences, Rokietnicka 5a, 60-806 Poznan, Poland.ORCID 0000-0003-3295-2789
Radosław KujawskiDepartment of Pharmacology, Poznań University of Medical Sciences, Rokietnicka 5a, 60-806 Poznan, Poland.ORCID 0000-0002-2389-0689
Justyna BaraniakDepartment of Pharmacology and Phytochemistry, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064 Plewiska, Poland.ORCID 0000-0001-7533-3078
Małgorzata Kania-DobrowolskaDepartment of Pharmacology and Phytochemistry, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064 Plewiska, Poland.ORCID 0000-0003-0128-6680
Ewa KamińskaDepartment of Pharmacology, Poznań University of Medical Sciences, Rokietnicka 5a, 60-806 Poznan, Poland.
Agnieszka GryszczyńskaDepartment of Pharmacology and Phytochemistry, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064 Plewiska, Poland.ORCID 0000-0002-8164-9914
Kamila Czora-PoczwardowskaDepartment of Pharmacology, Poznań University of Medical Sciences, Rokietnicka 5a, 60-806 Poznan, Poland.
Hanna WiniarskaDepartment of Pharmacology, Poznań University of Medical Sciences, Rokietnicka 5a, 60-806 Poznan, Poland.ORCID 0000-0002-9612-3819
Przemysław Ł MikołajczakDepartment of Pharmacology, Poznań University of Medical Sciences, Rokietnicka 5a, 60-806 Poznan, Poland.ORCID 0000-0002-1252-6523
Poznan University of Medical Sciences · PLInstitute of Natural Fibres and Medicinal Plants · PL

Funding

Polish Ministry of Science and Higher Education Grant No. NN 405 358737
6 · The paper itself

Abstract

The study was carried out on alcohol-preferring male Wistar rats. The following drugs were repeatedly (28×) administered: acamprosate (500 mg/kg, p.o.), naltrexone (0.1 mg/kg, i.p), and

Indexed as

acamprosatealcohol intakealcohol preferring ratsalcohol tolerancedaidzinghrelin blood levelnaltrexonePueraria lobatapuerarin

Identifiers

PMID35056082
PMCPMC8777655
OpenAlexW4200037366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.